Tag Archives: Theranos

stem.cell

Scottsdale hosts second Cure Corridor Event

Scottsdale economic development will be hosting the second annual Cure Corridor Event at the Scottsdale Fairmont Princess Dec. 5 from 11 a.m. to 1:30 p.m. This event features a significant lineup of Cure Corridor partners sharing their insight into the future of the Cure Corridor and Bio-Life Sciences Industry. Keynote speaker Elizabeth Holmes – founder and CEO of Theranos, which recently located at Scottsdale’s SkySong, will headline the event.  Ms. Holmes was recently featured on the cover of Forbes magazine and debuted on Forbes 400 as the youngest self-made woman billionaire.

The first annual Cure Corridor event was launched in September 2013 and entertained hundreds of attendees with strong presenter content. The City of Scottsdale’s goal is to raise awareness about the innovation activity taking place in the community while supporting business growth and collaboration among industry partners.

This year’s event brings together a multitude Scottsdale industry partners in bio-life science to share recent happenings in their core areas of research in a rapid fire presentation format. The current line-up of noted rapid fire speakers include:

• Martin Shultz – Arizona Bioscience Roadmap Steering Committee
• Dr. Michael Gordon – Medical Director of the Virginia G. Piper Cancer Center Clinical Trials program at Scottsdale Healthcare
• J.D. Weir – Primus Pharmaceuticals
• David Bennett – Orion Health
• Dr. Robert Greenes – ASU and Mayo Clinic
• Walter Cooper – Matrix Medical Network

“Our healthcare and life science community in Scottsdale is a vital economic sector and is as a key driver for job growth in our community,” said Mayor W.J. “Jim” Lane. “More importantly, leading life science innovators call Scottsdale “home.” This means that the people of our community have access to the best possible healthcare services, cutting edge research, and other opportunities that will benefit the people of Scottsdale today and for generations to come.”

The Cure Corridor is not only a location but a concept designed to promote the innovative activities occurring around the concentration of the Bio-Life Sciences sector throughout Scottsdale. This sector is a major driver of the innovation economy in the State of Arizona, Greater Phoenix region and City of Scottsdale. According to the Flinn Foundation, the biosciences in Arizona “develop treatments for health afflictions, design diagnostics to gauge and prevent illness, strengthen our food supply, develop alternative fuel sources, and much more.”

The Scottsdale Cure Corridor is more than a brand or location. This strategic concept includes activities designed to promote the innovative practices occurring around the concentration of biotech and life sciences industries from Shea Boulevard to the Scottsdale Airpark and throughout Scottsdale. The bio-life science sector has a strong presence in the city’s economic health, with Scottsdale housing 13 percent of all Phoenix Metro area bio-life sciences employment. The Scottsdale bio-life sciences activity includes a workforce of about 27,700 people and a direct economic output of $2.5 billion and indirect output of $3.5 billion annually anchored by companies such as TD2, Scottsdale Healthcare Research Institute and Mayo Clinic.

The Cure Corridor isn’t just home to some of the world’s most prestigious clinical research facilities it is also home to pharmaceutical companies such as Primus, Prismic and West Pharmaceuticals.

The health-service industry burst in 2014 with major location and expansion announcements by some of the fastest growing companies in the U.S.  Companies such Orion Health, ZocDoc, Zenefits and Accolade have all chosen Scottsdale because of its skilled workforce, high quality of life and a booming industry cluster which is drawing national recognition.

SkySong 3 Progress, WEB

Theranos leases 20KSF at SkySong 3

A major consumer healthcare innovator shaping the future of lab testing will plant a significant flag at SkySong, the ASU Scottsdale Innovation Center.

Theranos, based in Palo Alto, Calif., has leased a 20,000-square-foot wing at SkySong 3, making it one of the largest tenants in the entire SkySong project. Beating all expectations, SkySong 3 is now over 80% leased as it nears its opening later this summer.

The move by Theranos means hundreds of jobs will be created at SkySong in the short term, with that figure increasing significantly as the company continues to grow.

Founded in 2003 by Elizabeth Holmes, Theranos is working to shape the future of lab testing and the way health information is collected, analyzed, and communicated. Theranos, in the words of one media outlet, “could turn the diagnostics industry upside down” and has the potential to save Arizona taxpayers $1.3 billion dollars over the next decade. Their service provides Phoenix-area consumers with convenient access to less invasive and more affordable clinician-directed lab testing from blood samples as small as a few drops collected from a tiny finger stick. Theranos has a national partnership with Walgreens and has been rolling out its Wellness Centers inside Walgreens stores across the U.S., including 25 locations and counting in central Arizona.

With its SkySong agreement, Theranos is expanding its footprint in the Valley. The company currently has an office in Kierland, and its signature presence at SkySong is the perfect fit for its rapidly growing entrepreneurial endeavor. CBRE acted as the company’s commercial real estate agent.

Sunny Balwani, President & COO of Theranos, said the company was drawn to SkySong because of its growing reputation as a center of innovation and technology.

“The Phoenix-area community’s reception to our company has been excellent,” Balwani said. “Our commitment to innovation will create hundreds of new jobs and positively impact Arizona over the coming months and years. The SkySong center is an ideal fit for our company, and we are excited to be a part of the project.”

Sharon Harper, President & CEO of Plaza Companies, the master developer of the project, said that Theranos is exactly the kind of company that will not only grow and thrive at SkySong, but will further the project’s mission as a home to innovation and entrepreneurship.

“You really could not ask for a better match in terms of innovative culture,” Harper said. “Elizabeth Holmes is the epitome of the word “entrepreneur”. She has a true passion to change the way laboratory testing is done and could change the way we detect and treat disease. We are thrilled to have Theranos become part of the SkySong family and we know that they will feel right at home in our innovative setting.”

With SkySong 3 approaching full occupancy, leasing is now well underway for SkySong 4.  The four-story, 150,000 SF building which will front Scottsdale Road south of SkySong Boulevard, is scheduled to break ground in late 2014.  Along with SkySong 3 and 4, the SkySong development team is now leasing a planned 10,500 square foot retail building to be built on the northeast corner of Scottsdale Road and SkySong Boulevard. It’s part of the overall mixed-use vision for SkySong, which will include 1.2 million square feet of development when completed.

SkySong, the ASU Scottsdale Innovation Center is a home to a global business community that links technology, entrepreneurship, innovation, and education to position ASU and Greater Phoenix as global leaders of the knowledge economy.

SkySong is a 42-acre mixed use development designed to:

• Create an ecology of collaboration and innovation among high-profile technology enterprises and related researchers;
• Advance global business objectives of on-site enterprises;
• Raise Arizona’s profile as a global center of innovation through co-location of ASU’s strategic global partners; and
• Create a unique regional economic and social asset.

Companies located at SkySong enjoy a special relationship with Arizona State University, which has more than 73,000 students at four metropolitan Phoenix campuses. Its campus in Tempe is the single largest campus in the U.S., and is located less than three miles from SkySong.

In addition to locating its own innovative research units at the center, ASU provides tenants with direct access to relevant research, educational opportunities and cultural events on its campuses. Through ASU’s on-site operations, tenant companies have a single point of contact for introductions to researchers, faculty and programs to address their specific needs.